https://www.selleckchem.com/products/pp1.html
AIM Sarcopenia is a harmful condition in patients with chronic liver disease. However, the evaluation of body muscle mass requires expensive instrumentation. The sarcopenia index (SI) (creatinine / cystatin C × 10 has been reported to correlate with muscle volume. A calculated body muscle mass (CBMM) using creatinine, cystatin C, and bodyweight also correlates with muscle mass. We evaluated the applicability of using SIs and CBMMs as screening methods for sarcopenia. METHODS Patients (n = 303) with liver damage were evaluated for creatini
Like
Comment
Share
